Latest News, Announcements, and Press Releases

— Company immediately begins wind down of CodeXyme® cellulase enzyme program for production of cellulosic sugars for biofuels and bio-based chemicals– — Conference call today at 4:30 pm ET — REDWOOD CITY, Calif.–(BUSINESS WIRE)–Nov. 12, 2013– Codexis, Inc.…

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Nov. 5, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced the appointment of Greg Hughes, Ph.D., as Vice President, Strategic Alliance & Product Development, effective…

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Nov. 4, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced it will host a live conference call and audio webcast on Tuesday, November 12, 2013…

REDWOOD CITY, Calif., Oct 02, 2013 (BUSINESS WIRE) –Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced that it has been named as a finalist for the CPhI Pharma Awards…

— Conference call on August 15th at 4:30 pm ET — REDWOOD CITY, Calif.–(BUSINESS WIRE)–Aug. 9, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced financial results for the…

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Aug. 5, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced that the company has rescheduled the release of its second quarter financial results due to…

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Aug. 5, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced that the company has received notice from Dyadic International, Inc. alleging that Codexis is in…

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Jul. 24, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced it will host a live conference call and audio webcast on Wednesday, August 7, 2013…

BALA CYNWYD, Pa. & REDWOOD CITY, Calif.–(BUSINESS WIRE)–Jul. 15, 2013– Purolite Corporation and Codexis, Inc. (NASDAQ:CDXS) today announced a joint collaboration to develop and market immobilized enzymes for the pharmaceutical industry. Enzymes are immobilized through binding to inert…

REDWOOD CITY, Calif. & TORTONA, Italy–(BUSINESS WIRE)–Jun. 14, 2013– Codexis (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, and Chemtex, a leader in chemical engineering and renewable processes, today announced the successful scale-up…